Comparison of different in vitro tests to assess oral lipid-based formulations using a poorly soluble acidic drug

Journal of Drug Delivery Science and Technology

Volumn 20, Issue 2, 2010, Pages 143-148

  Arnold, Y ^a,b   Bravo Gonzalez, R ^c   Versace, H ^c   Kuentz, M ^a  

^a UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

Biorelevant media; Dispersion; Lipolysis; Oral drug absorption; Self microemulsifying drug delivery systems (sMEDDS)

Indexed keywords

DRUG CARRIER; INDOMETACIN; LIPID; MALEIC ANHYDRIDE; PANCREATIN; PEPSIN A; PHOSPHATIDYLCHOLINE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM HYDROXIDE; TAUROCHOLIC ACID;

ACIDITY; ARTICLE; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; IN VITRO STUDY; LIPOLYSIS; PRECIPITATION;

EID: 77950619099     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(10)50019-4     Document Type: Article

References (31)

1. Hong J.Y., Kim J.K., Song Y.K., Park J.S., Kim C.K. - A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. - J. Contr. Release, 110, 332-338, 2006.
2. Porter C., Pouton C.W., Cuine J.F., Charman W.N. - Enhancing intestinal drug solubilisation using lipid-based delivery systems. - Adv. Drug Del. Rev., 60, 673-691, 2008.
3. Pouton C.W. - Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. - Adv. Drug Del. Rev., 60, 625-637, 2008.
4. Strickley R.G. - Solubilizing excipients in oral and injectable formulations. - Pharm. Res., 21, 201-230, 2004.
5. Strickley R.G. - Currently marketed oral lipid-based dosage forms: drug products and excipients. - In: Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water Soluble Drugs, D.J. Hauss Ed., Informa Healthcare, Inc., New York, 2007, pp. 1-31.
6. Pouton C.W. - Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying, and self-microemulsifying drug delivery systems. - Eur. J. Pharm. Sci., 11 (2), S93-S98, 2000.
7. Pouton C.W. - Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. - Eur. J. Pharm. Sci., 29, 278-287, 2006.
8. Woo J.S., Song Y.K., Hong J.Y., Lim S., Kim C.K. - Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. - Eur. J. Pharm. Sci., 33, 159-165, 2007.
9. Mohsin K., Long M.A., Pouton C.W. - Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. - J. Pharm. Sci., 98 (10), 3582-3595, 2008.
10. Chen Y., Xianggen G.L., Chen Z., Hang J., Qin B., Chen S., Wang R. - Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. - Biol. Pharm. Bull., 31 (1), 118-125, 2008.
11. Zhang P., Liu Y., Feng N., Xu J. - Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. - Int. J. Pharm., 355, 269-276, 2008.
12. Zangenberg N.H., Müllertz A., Kristensen H.G., Hovgaard L. - A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. - Eur. J. Pharm. Sci., 14, 237-244, 2001.
13. Zangenberg N.H., Müllertz A., Kristensen H.G., Hovgaard L.- A dynamic in vitro lipolysis model. II. Evaluation of the model. - Eur. J. Pharm. Sci., 14, 237-244, 2001.
14. Cuiné J.F., McEvoy C.L., Charman W.N., Pouton C.W., Edwards G.A., Benameur H., Porter C.J. - Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dog. - J. Pharm. Sci., 97 (2), 995-1012, 2007.
15. Fernandez S., Jannin V., Rodier J., Ritter N., Mahler B., Carriere F. - Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. - Biochem. et Biopharm. Acta, Molecular and Cell Biology of Lipids, 1771 (5), 633-640, 2007.
16. Vertzoni M., Fotaki N., Kostewicz E., Stippler E., Leuner C., Nicolaides E., Dressman J., Reppas C. - Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. - J. Pharm. Pharmacol., 56, 453-462, 2004.
17. Vertzoni M., Dressman J., Butler J., Hempenstall J., Reppas C. - Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. - Eur. J. Pharm. Biopharm., 60, 413-417, 2005.
18. nd ed., Churchill Livingstone, Edinburgh, London, 1998, pp. 141-143.
19. Geigy J.R. - Pharma AG - Wissenschaftliche Tabellen, 7. Auflage - Documenta Geigy, Basel, 1973.
20. th ed., 2008.
21. Lunn G., Schmuff N.R. - HPLC Methods for Pharmaceutical Analysis. - Wiley, New York, 1997-2000.
22. Galia E., Nicolaides E., Hörter D., Löbenberg R., Reppas C., Dressman J.B. - Evaluation of various dissolution media for predicting in vivo performance of Class I and II drugs. - Pharm. Res., 15(5), 698-705, 1998.
23. Gursoy R.N., Benita S. - Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. - Biomed. & Pharmacoth., 58, 173-182, 2004. (Pubitemid 38479922)
24. Ditner C., Bravo R., Imanidis G., Kuentz M. - A systematic dilution study of self-microemulsifying drug delivery systems in artificial intestinal fluid using dynamic laser light backscattering. - Drug Dev. Ind. Pharm., 35, 199-208, 2009.
25. Gershanik T., Benita S. - Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. - Eur. J. Pharm. Biopharm., 50, 179-188, 2000.
26. Charman W.N., Porter C., Mithani S., Dressman J.B. - Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. - J. Pharm. Sci., 86 (3), 269-282, 1996.
27. Kostewicz E.S., Brauns U., Becker R., Dressman J.B. - Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. - Pharm. Res., 19, 345-349, 2001.
28. Hutchison K. - Digestible emulsions and microemulsions for optimum oral delivery of hydrophobic drugs. - B.T. Gattefossé, 87, 67-74, 1994.
29. Yazdanian M., Briggs K., Jankovsky C., Hawi A. - The "high solubility" definition of the Current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs. - Pharm. Res., 21 (2), 293-299, 2004.
30. Kuentz M. - Drug absorption modeling as a tool to define strategy in clinical formulations development. - AAPS J., 10 (3), 473-479, 2008.
31. Kim J.Y., Ku Y.S. - Enhanced absorption of Indomethacin after oral or rectal administration of a self-emulsifying system containing Indomethacin in rats. - Int. J. Pharm., 194, 81-89, 2000.